Literature DB >> 2318982

Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.

A Kukita1, C Chenu, L M McManus, G R Mundy, G D Roodman.   

Abstract

Although Paget's disease is the most flagrant example of a primary osteoclast disorder, little is known of osteoclast biology in this disease. In this report we have studied the formation of cells with the osteoclast phenotype in long-term cultures of marrow mononuclear cells derived from patients with Paget's disease, and compared these with similar cells formed in long-term marrow cultures from normal individuals, and with osteoclasts present in pagetic bone. Osteoclasts formed in pagetic marrow cultures resembled osteoclasts present in pagetic bone, but were distinctly different from osteoclasts formed in normal marrow cultures. Osteoclast formation was 10-20-fold greater in pagetic marrow cultures than in normal cultures. The multinucleated cells formed in cultures of pagetic marrow were much larger in size, were hyperresponsive to 1,25(OH)2 vitamin D, had more nuclei per cell, had increased levels of tartrate-resistant acid phosphatase activity and had ultrastructural features which were not seen in multinucleated cells formed from normal marrow mononuclear cells. These pagetic marrow-derived multinucleated cells formed large resorption lacunae on calcified matrices and cross-reacted with monoclonal antibodies which preferentially bind to osteoclasts. The multinucleated cells formed from marrow obtained from uninvolved sites in Paget's patients also displayed these abnormal features.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318982      PMCID: PMC296564          DOI: 10.1172/JCI114565

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Optical and scanning electron microscopy in the single osteoclast resorption assay.

Authors:  A Boyde; N N Ali; S J Jones
Journal:  Scan Electron Microsc       Date:  1985

Review 2.  Metabolic consequences of bone turnover in Paget's disease of bone.

Authors:  S M Krane; L S Simon
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

3.  Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.

Authors:  M F Basle; A Rebel; J C Renier; M Audran; R Filmon; K Malkani
Journal:  Clin Orthop Relat Res       Date:  1984-04       Impact factor: 4.176

Review 4.  Experimental basis for the use of bisphosphonates in Paget's disease of bone.

Authors:  H Fleisch
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

Review 5.  On the trail of paramyxoviruses in Paget's disease of bone.

Authors:  M F Baslé; A Rebel; J G Fournier; W C Russell; K Malkani
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

6.  1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow.

Authors:  G D Roodman; K J Ibbotson; B R MacDonald; T J Kuehl; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Variation in the sizes of resorption lacunae made in vitro.

Authors:  S J Jones; A Boyde; N N Ali; E Maconnachie
Journal:  Scan Electron Microsc       Date:  1986

Review 8.  Long-term follow-up observations on treatment in Paget's disease of bone.

Authors:  J A Kanis; R E Gray
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

9.  Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization.

Authors:  M F Baslé; J G Fournier; S Rozenblatt; A Rebel; M Bouteille
Journal:  J Gen Virol       Date:  1986-05       Impact factor: 3.891

10.  Paramyxovirus antigens in osteoclasts from Paget's bone tissue detected by monoclonal antibodies.

Authors:  M F Basle; W C Russell; K K Goswami; A Rebel; P Giraudon; F Wild; R Filmon
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

View more
  22 in total

Review 1.  Paget's disease of bone: a disease of the osteoclast.

Authors:  S V Reddy; N Kurihara; C Menaa; G D Roodman
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro.

Authors:  K Piper; A Boyde; S J Jones
Journal:  Anat Embryol (Berl)       Date:  1992-09

3.  Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.

Authors:  Noriyoshi Kurihara; Yuko Hiruma; Kei Yamana; Laëtitia Michou; Côme Rousseau; Jean Morissette; Deborah L Galson; Jumpei Teramachi; Hua Zhou; David W Dempster; Jolene J Windle; Jacques P Brown; G David Roodman
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

4.  Cellular immunodeficiency in Paget's disease of bone: changes induced by treatment with elcatonin.

Authors:  A Rapado; M Yague; M Diaz Curiel; F Ortiz; P Palomino; C de la Piedra; R Torres; B Peramo; E Lopez Gavilanes
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

5.  Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

Authors:  G D Roodman; N Kurihara; Y Ohsaki; A Kukita; D Hosking; A Demulder; J F Smith; F R Singer
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

6.  Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.

Authors:  Kazuaki Miyagawa; Yasuhisa Ohata; Jesus Delgado-Calle; Jumpei Teramachi; Hua Zhou; David D Dempster; Mark A Subler; Jolene J Windle; John M Chirgwin; G David Roodman; Noriyoshi Kurihara
Journal:  JCI Insight       Date:  2020-03-26

7.  Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease.

Authors:  Jumpei Teramachi; Yuki Nagata; Khalid Mohammad; Yuji Inagaki; Yasuhisa Ohata; Theresa Guise; Laëtitia Michou; Jacques P Brown; Jolene J Windle; Noriyoshi Kurihara; G David Roodman
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

8.  Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.

Authors:  Jumpei Teramachi; Yuko Hiruma; Seiichi Ishizuka; Hisako Ishizuka; Jacques P Brown; Laëtitia Michou; Huiling Cao; Deborah L Galson; Mark A Subler; Hua Zhou; David W Dempster; Jolene J Windle; G David Roodman; Noriyoshi Kurihara
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

9.  A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.

Authors:  Yuko Hiruma; Noriyoshi Kurihara; Mark A Subler; Hua Zhou; Christina S Boykin; Heju Zhang; Seiichi Ishizuka; David W Dempster; G David Roodman; Jolene J Windle
Journal:  Hum Mol Genet       Date:  2008-09-02       Impact factor: 6.150

10.  An assessment of the ability of human bone marrow cultures to generate osteoclasts.

Authors:  A M Flanagan; M A Horton; E L Dorey; D A Collins; R S Evely; J M Moseley; F C Firkin; T J Chambers; M H Helfrich; T J Martin
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.